General Moly, Inc. (NYSEMKT:GMO) (TSE:GMO) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Monday.
According to Zacks, “General Moly is a U.S.-based molybdenum mineral exploration and development company listed on the American Stock Exchange and the Toronto Stock Exchange under the symbol GMO. Their primary asset, their interest in the Mt. Hope project located in central Nevada, is considered one of the world’s largest and highest grade molybdenum deposits. Combined with their second molybdenum property, the Hall-Tonopah project which is also located in central Nevada. Their goal is to become the largest primary molybdenum producer by the middle of the next decade. “
Shares of General Moly (NYSEMKT:GMO) traded down 1.254% during midday trading on Monday, hitting $0.315. 240,606 shares of the stock were exchanged. The firm’s market cap is $34.83 million. The firm’s 50-day moving average is $0.25 and its 200 day moving average is $0.31. General Moly has a 52-week low of $0.15 and a 52-week high of $0.47.
General Moly Company Profile